Ingrid Lieber

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Prognostic Factors

Patient Reported Outcomes

Ejection Fraction

Top Venues

Journal of clinical medicine

Therapeutic advances in psychopharmacology

Journal of psychopharmacology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Ingrid Lieber, Michael Ott, Robert Lundqvist, Mats Eliasson, Ursula Werneke
Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study. Therapeutic advances in psychopharmacology 13 (2023)
Ingrid Lieber, Michael Ott, Robert Lundqvist, Mats Eliasson, Ursula Werneke
Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study. Therapeutic advances in psychopharmacology 13 (2023)
Ingrid Lieber, Michael Ott, Robert Lundquist, Mats Eliasson, Mikael Sandlund, Ursula Werneke
Elevated Thyroxine Concentration and Lithium Intoxication-An Analysis Based on the LiSIE Retrospective Cohort Study. Journal of clinical medicine 11 (11) (2022)
Ingrid Lieber, Michael Ott, Louise Öhlund, Robert Lundquist, Mats Eliasson, Mikael Sandlund, Ursula Werneke
Patterns of Thyroid Hormone Prescription in Patients with Bipolar or Schizoaffective Disorder: Findings from the LiSIE Retrospective Cohort Study. Journal of clinical medicine 10 (21) (2021)
Ingrid Lieber, Michael Ott, Louise Öhlund, Robert Lundqvist, Mats Eliasson, Mikael Sandlund, Ursula Werneke
Lithium-associated hypothyroidism and potential for reversibility after lithium discontinuation: Findings from the LiSIE retrospective cohort study. Journal of psychopharmacology (Oxford, England) 34 (3) (2019)